Literature DB >> 1396842

Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy.

J R Kieny1, A Sacrez, A Facello, R Arbogast, P Bareiss, G Roul, J L Demangeat, B Brunot, A Constantinesco.   

Abstract

To assess the potential improvement in left ventricular ejection fraction after cardioversion of chronic atrial fibrillation to sinus rhythm in idiopathic dilated cardiomyopathy, we studied prospectively 17 patients, aged 58 +/- 6 years, by radionuclide angiocardiography at rest. Left ventricular ejection fraction was determined before treatment and at a mean delay of 4.7 months after cardioversion. Return to sinus rhythm was obtained in 12 patients, pharmacologically or by electrical cardioversion. Five patients remained in atrial fibrillation. No clinical, echocardiographic or haemodynamic finding could predict the success of cardioversion. In chronic atrial fibrillation, the ejection fraction did not change significantly: 30.0 +/- 9.1% (19 to 44%) at the first evaluation and 29.5 +/- 8.3% (22 to 41%) after 4.7 months. After successful cardioversion, left ventricular ejection fraction improved from 32.1 +/- 5.3% (24 to 41%) to 52.9 +/- 9.7% (37 to 71%) (P less than 0.001). The difference was 20.8 +/- 11.3% and left ventricular ejection fraction was normalized in 50% (6/12) of the patients. There was a significant reduction in the cardiothoracic ratio on chest X-rays and of the left ventricular end-diastolic diameter on echocardiography; fractional shortening increased (27.7 +/- 4.3% vs 20.3 +/- 2.7%, P less than 0.01). A third evaluation was realized after a mean delay of 11.7 months in the patients with successful cardioversion. Sinus rhythm was present in 83% (10/12) of the patients: seven patients were reevaluated by radionuclide angiography. The improvement in left ventricular function observed at the 4.7 months evaluation was still present. In two patients with recurrence of atrial fibrillation, there was a severe deterioration of left ventricular systolic function.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1396842     DOI: 10.1093/oxfordjournals.eurheartj.a060351

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  18 in total

Review 1.  Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Authors:  I Savelieva; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

Review 2.  Prevention of relapse in patients with congestive heart failure: the role of precipitating factors.

Authors:  J Feenstra; D E Grobbee; F A Jonkman; A W Hoes; B H Stricker
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

3.  Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation.

Authors:  G Nichol; F McAlister; B Pham; A Laupacis; B Shea; M Green; A Tang; G Wells
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

Review 4.  Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation.

Authors:  Gerald V Naccarelli; John Hynes; Deborah L Wolbrette; Luna Bhatta; Mazhar Khan; Jerry Luck
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

5.  Estimation of left ventricular contractile performance in atrial fibrillation: experimental and clinical studies.

Authors:  R Tanaka; M Tomita; T Noda; K Kagawa; K Nishigaki; M Yamaguchi; A Kunishima; H Fujiwara
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

Review 6.  Atrial fibrillation: how to approach rate control.

Authors:  Lynda E Rosenfeld
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

7.  Atrial and ventricular function after cardioversion of atrial fibrillation.

Authors:  C Xiong; C Sonnhag; E Nylander; B Wranne
Journal:  Br Heart J       Date:  1995-09

8.  Prevalence and prognostic significance of left ventricular dysfunction in patients presenting acutely with atrial fibrillation.

Authors:  Chin Lin; Colin Edwards; Guy P Armstrong; Anthony Scott; Hitesh Patel; Hamish Hart; Jonathan P Christiansen
Journal:  Clin Med Insights Cardiol       Date:  2010-03-12

9.  Atrial fibrillation ablation and heart failure.

Authors:  Jonathan Man; Francis E Marchlinski
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

Review 10.  Heart failure and tachycardia-induced cardiomyopathy.

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Curr Heart Fail Rep       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.